Meeting Banner
Abstract #2547

MRI enhancement of TPP-TEMPOL during reduces kidney damage

Quan Tao1, Peiwei Yi1, Zimeng Cai1, Yingjie Mei2, Ruiyuan Liu1, and Yanqiu Feng1
1School of Biomedical Engineering, Southern Medical University, Guangzhou, China, 2Philips healthcare, Guangzhou, China

In this study, we synthesis a mitochondria-targeted contrast agent named triphenylphosphine-2,2,6,6-tetramethylpiperidine-1-oxyl (TPP-TEMPOL) to protect the kidney from the damage induced by rhabdomyolysis. At the same time, measured the T1 changes by MRI.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords